Oct 6, 2026 07:00AM

Aug 13, 2026 04:05PM

Aug 13, 2026 09:10AM

Aug 13, 2026 09:10AM

Jul 27, 2026 09:09AM

Jul 27, 2026 07:00AM

Jul 27, 2026 07:00AM MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

Jun 22, 2026 07:00AM

Jun 22, 2026 07:00AM

May 14, 2026 04:05PM

Mar 26, 2026 07:00AM

Jan 5, 2026 07:03AM

Jan 5, 2026 07:00AM

Nov 21, 2025 12:57AM Morgan Stanley Starts MapLight Therapeutics (MPLT) at Overweight

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All